On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Sunday, October 04, 2026
When Liver Signals Stall Late-Stage Pipelines: The Critical Role of Pre-Market DILI (Drug-Induced Liver Injury) Assessment
›
A recent report by BioSpace “ BMS reports liver injury events in lung disease program, with key readout near ” detailing liver injury event...
Sunday, July 26, 2026
Comparative Analysis of Statistical Reporting Guidelines: The New England Journal of Medicine vs. The Lancet
›
Recently, while working on manuscripts submitted to The New England Journal of Medicine and The Lancet , I had the opportunity to compare ...
›
Home
View web version